If projected changes in population growth and aging hold, a “tidal wave” of cancer cases could increase the worldwide prevalence by 77% over the next 25 years. (CA: A Cancer Journal for Clinicians)
A cancer “previvor” clinic offers services and support for patients who are carriers of BRCA mutations. (Cedars-Sinai Medical Center)
A bacteria implicated in gum disease might also have a link to some colon cancers. (NIH)
The American Lung Association has launched a public education campaign to increase awareness and understanding about lung nodules.
More than 20% of Americans participate in clinical research involving cancer. (Fred Hutchinson Cancer Center, Journal of Clinical Oncology)
The FDA expanded the approval of idecabtagene vicleucel (Abecma) in relapsed or refractory multiple myeloma; the CAR T-cell therapy can now be used to treat triple-class exposed patients after two prior lines of treatment, Bristol Myers Squibb announced.
AstraZeneca announced that a phase III trial showed that durvalumab (Imfinzi) significantly improved overall survival and progression-free survival (PFS) in limited-stage small cell lung cancer that had not progressed after concurrent chemoradiotherapy.
Gritstone bio announced that a phase II study of its personalized cancer vaccine improved PFS as initial therapy for metastatic microsatellite stable colorectal cancer.
Researchers “do not see an obvious path forward” for the targeted drug tomivosertib, which did not meet the prespecified endpoint of improved PFS in advanced non-small cell lung cancer when added to pembrolizumab (Keytruda), eFFECTOR Therapeutics announced.
Just when you thought you had sorted out the health issues surrounding regular coffee, health advocacy groups have set their sights on a ban of a chemical commonly found in decaf. (CNN)
An oncologist offers cautionary tales about cancer patients’ use of cannabis. (The Guardian)
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/charlesBankhead_188.jpg)
Please enable JavaScript to view the